[{"Assets_0_Q3_USD":"125536000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.45","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.83","EarningsPerShareBasic_3_Q3_USD":"0.45","EarningsPerShareDiluted_1_Q3_USD":"0.82","EarningsPerShareDiluted_3_Q3_USD":"0.44","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","MinorityInterest_0_Q3_USD":"72000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"10382000000.0","NetIncomeLoss_1_Q3_USD":"1872000000.0","NetIncomeLoss_3_Q3_USD":"1012000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","PaymentsOfDividends_3_Q3_USD":"3054000000.0","ProfitLoss_1_Q3_USD":"1878000000.0","ProfitLoss_3_Q3_USD":"1032000000.0","RevenuesConverted_1_Q3_USD":"10540000000.0","RevenuesConverted_3_Q3_USD":"31450000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"50230000000.0","StockholdersEquity_0_Q3_USD":"50158000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"2290000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"2295000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"2257000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"2260000000.0","filed":"20201105","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"BRISTOL MYERS SQUIBB CO","period":"20200930","qtrs":"1","uom":"USD"}]